Accreditation Information

CME Credit:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Weston Medical Publishing, LLC.  Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit:

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by Weston Medical Publishing, LLC.

Contact Hours: 18.25, of which up to 18.25 are eligible for pharmacology credit.

CPE Credit: 

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 7.50 contact hours (0.75 ceus) on day one, 7.50 contact hours (0.75 ceus) on day two, and 3.5 (0.35 ceus) on day three of the “International Conference on Opioids” June 11-13, 2017.

Pharmacists must attend the full day of educational activities to earn ce credit for the day.

Universal Activity Numbers: International Conference on Opioids, Day One (Sunday June 11, 2017) UAN 0060-9999-17-036-L01-P
International Conference on Opioids, Day Two (Monday June 12, 2017) UAN 0060-9999-17-037-L01-P
International Conference on Opioids, Day Three (Tuesday June 13, 2017) UAN 0060-9999-17-038-L01-P

Objectives

  • Describe the physiology of pain, the different types of pain and their varied manifestations.
  • Assess the diversity of patients’ responses to pain, and the rationale for choices of pain control methods.
  • Articulate the latest evidence highlighting the efficacy, safety, and side effect profile of opioid treatment for chronic nonmalignant pain.
  • Manage patients with chronic pain using best practices for the use of opioids and the tools to assess and prevent prescription opioid misuse.
  • Communicate guidelines and best practices to properly manage care for a patient with both chronic pain and a history of addiction.
  • Describe the enhanced therapeutic benefits of various opioids combined with a safety profile, and highlighting indications for use in chronic and cancer pain, as well as profiles of side effects.

Target Audience

Primary Care Physicians, Pain Specialists, Pharmacists and other Opioid Prescribers

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by Boston University are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.